Effects of rosiglitazone treatment on serum amyloid-beta 1-40 and 1-42 in patients with early Alzheimer's disease

被引:2
|
作者
Kulstad, J
Green, PS
Cook, DG
Watson, GS
Reger, M
Cholerton, B
Baker, LD
Plymate, SR
Asthana, S
Fishel, M
Kahn, SE
Craft, S
机构
[1] Univ Washington, Seattle, WA 98195 USA
[2] VA Med Ctr, Seattle, WA USA
[3] Univ Wisconsin, Madison, WI USA
[4] William S Middleton Mem Vet Adm Med Ctr, Madison, WI USA
关键词
D O I
10.1016/S0197-4580(04)81167-9
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
引用
收藏
页码:S354 / S355
页数:2
相关论文
共 50 条
  • [31] Cerebrospinal β-amyloid 1-40 and 1-42 concentrations in healthy subjects
    Hizli, B. Z.
    Ilcol, Y. O.
    CLINICAL CHEMISTRY, 2006, 52 (06) : A155 - A155
  • [32] A Novel Automated Chemiluminescence Method for Detecting Cerebrospinal Fluid Amyloid-Beta 1-42 and 1-40, Total Tau and Phosphorylated-Tau: Implications for Improving Diagnostic Performance in Alzheimer's Disease
    Arcaro, Marina
    Fenoglio, Chiara
    Serpente, Maria
    Arighi, Andrea
    Fumagalli, Giorgio G.
    Sacchi, Luca
    Floro, Stefano
    D'Anca, Marianna
    Sorrentino, Federica
    Visconte, Caterina
    Perego, Alberto
    Scarpini, Elio
    Galimberti, Daniela
    BIOMEDICINES, 2022, 10 (10)
  • [33] Utility of an improved model of amyloid-beta (Aβ1-42) toxicity in Caenorhabditis elegansfor drug screening for Alzheimer’s disease
    Gawain McColl
    Blaine R Roberts
    Tara L Pukala
    Vijaya B Kenche
    Christine M Roberts
    Christopher D Link
    Timothy M Ryan
    Colin L Masters
    Kevin J Barnham
    Ashley I Bush
    Robert A Cherny
    Molecular Neurodegeneration, 7
  • [34] Memory decline correlates with increased plasma cytokines in amyloid-beta (1-42) rat model of Alzheimer's disease
    Shallie, Oluwadamilola F.
    Dalle, Ernest
    Mabandla, Musa V.
    NEUROBIOLOGY OF LEARNING AND MEMORY, 2020, 169
  • [35] Utility of an improved model of amyloid-beta (Aβ1-42) toxicity in Caenorhabditis elegans for drug screening for Alzheimer's disease
    McColl, Gawain
    Roberts, Blaine R.
    Pukala, Tara L.
    Kenche, Vijaya B.
    Roberts, Christine M.
    Link, Christopher D.
    Ryan, Timothy M.
    Masters, Colin L.
    Barnham, Kevin J.
    Bush, Ashley I.
    Cherny, Robert A.
    MOLECULAR NEURODEGENERATION, 2012, 7
  • [36] Familial Alzheimer's disease-linked presenilin 1 variants elevate A beta 1-42/1-40 ratio in vitro and in vivo
    Borchelt, DR
    Thinakaran, G
    Eckman, CB
    Lee, MK
    Davenport, F
    Ratovitsky, T
    Prada, CM
    Kim, G
    Seekins, S
    Yager, D
    Slunt, HH
    Wang, R
    Seeger, M
    Levey, AI
    Gandy, SE
    Copeland, NG
    Jenkins, NA
    Price, DL
    Younkin, SG
    NEURON, 1996, 17 (05) : 1005 - 1013
  • [37] Blood brain barrier transport of Alzheimer's amyloid beta peptides Aβ1-40 and Aβ1-42.
    Fuller, L
    Miao, W
    Mackic, J
    Zlokovic, B
    JOURNAL OF INVESTIGATIVE MEDICINE, 1998, 46 (01) : 168A - 168A
  • [38] The Cerebrospinal Fluid Aβ1-42/Aβ1-40 Ratio Improves Concordance with Amyloid-PET for Diagnosing Alzheimer's Disease in a Clinical Setting
    Niemantsverdriet, Ellis
    Ottoy, Julie
    Somers, Charisse
    De Roeck, Ellen
    Struyfs, Hanne
    Soetewey, Femke
    Verhaeghe, Jeroen
    Van den Bossche, Tobi
    Van Mossevelde, Sara
    Goeman, Johan
    De Deyn, Peter Paul
    Marien, Peter
    Versijpt, Jan
    Sleegers, Kristel
    Van Broeckhoven, Christine
    Wyffels, Leonie
    Albert, Adrien
    Ceyssens, Sarah
    Stroobants, Sigrid
    Staelens, Steven
    Bjerke, Maria
    Engelborghs, Sebastiaan
    JOURNAL OF ALZHEIMERS DISEASE, 2017, 60 (02) : 561 - 576
  • [39] Clinical usefulness of the CSF β-amyloid Aβ1-42/Aβ1-40 ratio for Alzheimer’s disease diagnosis: a retrospective study in a Belgian academic hospital
    Matthieu Deltombe
    Catherine Fillee
    Vincent van Pesch
    Acta Neurologica Belgica, 2022, 122 : 245 - 247
  • [40] Role of the Aβ1-42/Aβ1-40 ratio in the concept 'Alzheimer's disease contributes to mild cognitive impairment'
    Monge-Garcia, Victoria
    Llorca-Tolon, Lourdes
    Gasparini-Berenguer, Ruth
    Monge-Argiles, Jose A.
    REVISTA DE NEUROLOGIA, 2021, 72 (11) : 371 - 376